Related Experiment Video
Updated: Aug 9, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
The prevention and management of autosomal recessive conditions. Main example: alpha 1-antitrypsin deficiency
1Department of Clinical Genetics, University Hospital, Uppsala, Sweden.
Insights
Newborn screening and genetic testing for treatable autosomal recessive disorders can improve health outcomes. Future approaches may include prenatal diagnosis and in-utero treatment for conditions like cystic fibrosis.
Area of Science:
- Genetics
- Public Health
- Medical Screening
Background:
- Autosomal recessive disorders are common in certain populations.
- Early diagnosis and treatment are crucial for managing these conditions.
- Advances in genetic testing are expanding screening possibilities.
Purpose of the Study:
- To explore the benefits of newborn screening for treatable autosomal recessive disorders.
- To discuss the potential of carrier screening and prenatal diagnosis for severe, non-treatable disorders.
- To highlight future directions in fetal and newborn treatment.
Main Methods:
- Review of current screening and diagnostic practices for genetic disorders.
- Discussion of emerging technologies in genetic carrier testing and prenatal diagnosis.
- Exploration of potential therapeutic interventions for affected fetuses and newborns.
Main Results:
- Newborn screening is effective for treatable disorders like alpha-1-antitrypsin deficiency (alpha 1-AT).
- Carrier testing for conditions such as cystic fibrosis is becoming increasingly available.
- Prenatal diagnosis allows for informed reproductive choices.
Conclusions:
- Population screening and early intervention significantly improve management of genetic disorders.
- Genetic carrier screening and prenatal diagnosis offer valuable reproductive options.
- Future research aims for in-utero treatment and correction of genetic disorders.
Abstract:
In populations in which a particular autosomal recessive disorder is treatable and relatively common, and for which there is a simple diagnostic test, newborns can be screened and treated. For some disorders, such as alpha 1-AT, young people can be screened and given appropriate advice to ameliorate the future symptoms. For some severe common and non-treatable autosomal recessive disorders, for example cystic fibrosis, carrier tests will probably soon be available for population screening of young people. Couples found to be carriers can then be offered prenatal diagnosis and termination of the pregnancy, if the fetus is affected. In the not-too-distant future the approaches will hopefully be treatment and correction of these disorders in the affected fetus or newborn.
Related Concept Videos
Pedigree Analysis
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Atherosclerosis III: Management

